Soleus Capital Management, L.P.
Q2 2026 13F filing
Updated 30 days ago97 disclosed positions worth $2.9B
Full holdings
Every line item disclosed in Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | K KRYS KRYSTAL BIOTECH INC | $349.1M | 939.3K | 12.03% | — |
| 2 | C CELC CELCUITY INC | $178.3M | 1.70M | 6.14% | — |
| 3 | T TGTX TG THERAPEUTICS INC | $160.9M | 2.93M | 5.54% | — |
| 4 | P PODD INSULET CORP | $159.7M | 1.05M | 5.50% | — |
| 5 | N NVCR NOVOCURE LTD | $150.2M | 9.91M | 5.18% | — |
| 6 | U UTHR UNITED THERAPEUTICS CORP DEL | $122.2M | 225.6K | 4.21% | — |
| 7 | I INSP INSPIRE MED SYS INC | $86.2M | 1.93M | 2.97% | — |
| 8 | R RIGL RIGEL PHARMACEUTICALS INC | $72.1M | 1.84M | 2.49% | — |
| 9 | A ANIP ANI PHARMACEUTICALS INC | $71.8M | 867.8K | 2.48% | — |
| 10 | B BHPLF BETA BIONICS INC | $68.8M | 4.39M | 2.37% | — |
| 11 | V VCEL VERICEL CORP | $64.9M | 1.46M | 2.24% | — |
| 12 | P PRAX PRAXIS PRECISION MEDICINES I | $59.4M | 177.5K | 2.05% | — |
| 13 | G GERN GERON CORP | $54.8M | 42.81M | 1.89% | — |
| 14 | A ALKS ALKERMES PLC | $53.9M | 1.03M | 1.86% | — |
| 15 | E EQR ERASCA INC | $49.5M | 2.70M | 1.70% | — |
| 16 | N NPCE NEUROPACE INC | $46.3M | 2.91M | 1.59% | — |
| 17 | P PGNY PROGYNY INC | $46.2M | 1.60M | 1.59% | — |
| 18 | I INDV INDIVIOR PHARMACEUTICALS INC | $43.7M | 1.06M | 1.50% | — |
| 19 | P PBLS PARABILIS MEDICINES INC | $40.1M | 1.47M | 1.38% | — |
| 20 | F FOCL EDAP TMS S A | $37.9M | 7.31M | 1.30% | — |
| 21 | G GMED GLOBUS MED INC | $37M | 468.9K | 1.28% | — |
| 22 | R RCUS ARCUS BIOSCIENCES INC | $36M | 1.17M | 1.24% | — |
| 23 | S SNDX SYNDAX PHARMACEUTICALS INC | $35.6M | 1.63M | 1.23% | — |
| 24 | N NRIX NURIX THERAPEUTICS INC | $35.5M | 1.47M | 1.22% | — |
| 25 | L LEGN LEGEND BIOTECH CORP | $34.8M | 1.21M | 1.20% | — |
| 26 | J JBIO JADE BIOSCIENCES INC | $34.5M | 1.55M | 1.19% | — |
| 27 | U UNH UNITEDHEALTH GROUP INC | $33.3M | 80.0K | 1.15% | — |
| 28 | ? N/A AVALO THERAPEUTICS INC | $30.6M | 1.65M | 1.05% | — |
| 29 | U URGN UROGEN PHARMA LTD | $30.5M | 829.8K | 1.05% | — |
| 30 | M MBX MBX BIOSCIENCES INC | $28.4M | 515.3K | 0.98% | — |
| 31 | ? N/A PALISADE BIO INC | $27.3M | 13.06M | 0.94% | — |
| 32 | P PHVS PHARVARIS N V | $25.3M | 730.9K | 0.87% | — |
| 33 | O ORGO ORGANOGENESIS HLDGS INC | $24.6M | 10.14M | 0.85% | — |
| 34 | S SUPN SUPERNUS PHARMACEUTICALS | $24.2M | 520.0K | 0.83% | — |
| 35 | P PRCT PROCEPT BIOROBOTICS CORP | $22.6M | 1.00M | 0.78% | — |
| 36 | T TNGX TANGO THERAPEUTICS INC | $22.2M | 709.0K | 0.76% | — |
| 37 | I IKT INHIBIKASE THERAPEUTICS INC | $22.1M | 10.88M | 0.76% | — |
| 38 | T TRVI TREVI THERAPEUTICS INC | $22M | 1.18M | 0.76% | — |
| 39 | B BMRN BIOMARIN PHARMACEUTICAL INC | $21.5M | 375.6K | 0.74% | — |
| 40 | L LIVN LIVANOVA PLC | $21M | 255.0K | 0.72% | — |
| 41 | A ARGX ARGENX SE | $18.5M | 20.0K | 0.64% | — |
| 42 | ? N/A NUVECTIS PHARMA INC | $18.4M | 1.00M | 0.63% | — |
| 43 | C CAPR CAPRICOR THERAPEUTICS INC | $18.3M | 761.7K | 0.63% | — |
| 44 | E EWTX EDGEWISE THERAPEUTICS INC | $18.3M | 450.9K | 0.63% | — |
| 45 | P PRLD PRELUDE THERAPEUTICS INC | $18M | 3.38M | 0.62% | — |
| 46 | X XENE XENON PHARMACEUTICALS INC | $16.1M | 267.0K | 0.56% | — |
| 47 | B BEPC C4 THERAPEUTICS INC | $15.8M | 3.38M | 0.54% | — |
| 48 | K KNSA KINIKSA PHARMACEUTICALS INTL | $15.8M | 246.4K | 0.54% | — |
| 49 | K KIDS ORTHOPEDIATRICS CORP | $14M | 732.1K | 0.48% | — |
| 50 | A AVLN AVALYN PHARMACEUTICALS INC | $13.8M | 419.0K | 0.48% | — |